Why Illumina Jumped 9.8% in November
Shares of the genomic sequencing specialist Illumina (NASDAQ: ILMN) rose nearly 10% in November, according to data from S&P Global Market Intelligence. However, there wasn't any company-specific news that can justify the move. Shareholders can likely chalk up the jump to continued enthusiasm for the company's breakout year.
Image source: Getty Images.
While there wasn't any big news released during the month, the company did have a few positive announcements to make, including:
Source: Fool.com
Illumina Inc. Stock
€120.86
1.820%
The stock is one of the favorites of our community with 33 Buy predictions and 4 Sell predictions.
As a result the target price of 161 € shows a positive potential of 33.21% compared to the current price of 120.86 € for Illumina Inc..
